|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.35 TWD | +0.82% |
|
-3.89% | -11.79% |
| 04-09 | TWi Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | TWi Biotechnology, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
TWi Biotechnology, Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported net loss was TWD 40.67 million compared to TWD 38.8 million a year ago. Basic loss per share from continuing operations was TWD 0.6 compared to TWD 0.58 a year ago.
Diluted loss per share from continuing operations was TWD 0.6 compared to TWD 0.58 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.79% | 33.36M | |
| +54.05% | 63.85B | |
| -2.02% | 41.83B | |
| +40.01% | 40.47B | |
| -10.22% | 27.17B | |
| +13.42% | 26.52B | |
| -21.60% | 18.69B | |
| +2.89% | 12.73B | |
| +22.40% | 12.11B | |
| +27.49% | 12.07B |
TWI BIOTECHNOLOGY, INC. 
